Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine
Graham Parsons,1 Cindy Ragbir,1 Oscar D’Agnone,2 Ayana Gibbs,3 Richard Littlewood,4 Bernadette Hard5 1Turning Point, London, UK; 2The OAD Clinic, London, UK; 3Camurus Ltd, Cambridge, UK; 4applied strategic, London, UK; 5Kaleidoscope Drug Project, Cardiff, Wales, UKCorrespondence: Bernadett...
Saved in:
Main Authors: | Parsons G (Author), Ragbir C (Author), D'Agnone O (Author), Gibbs A (Author), Littlewood R (Author), Hard B (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis
by: Wright N, et al.
Published: (2020) -
Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations
by: Joanne Neale, et al.
Published: (2019) -
Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
by: Phillips-Jackson H, et al.
Published: (2020) -
Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
by: Craig V. Towers, et al.
Published: (2020) -
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
by: Alane B. O'Connor, et al.
Published: (2024)